Studies on the IgA-independent immunological responses in mice to influenza virus challenge after oral vaccination with irradiated whole virus and an erythrocyte complex

Immunology and Cell Biology

Volumn 78, Issue 2, 2000, Pages 149-155

  Lidbury, Brett A ^a,b   Grissell, Terrence V ^a   Sizer, Philip J ^a,c   Clancy, Robert ^a   Cripps, Allan W ^a,b  

^a ROYAL NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

^c Provalis UK Ltd   (United Kingdom)

Author keywords

Erythrocyte complex, immunoglobulin A response; Influenza virus; Irradiated virus; Oral vaccination

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; INFLUENZA VACCINE; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ERYTHROCYTE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA VACCINATION; INFLUENZA VIRUS; MALE; MOUSE; NONHUMAN; SPLEEN CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; CELLS, CULTURED; CYTOKINES; ERYTHROCYTES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINES; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED CBA; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; SPLEEN; VACCINES, INACTIVATED;

ANIMALIA; INFLUENZA VIRUS;

EID: 0034105629     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00898.x     Document Type: Article

References (22)

1. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 1997; 159: 105-17.
2. 2 Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 1997; 159: 95-103.
3. 3 Couch RB, Cate TR, Keitel WA. Oral immunisation with influenza virus vaccines. In: Kiyono H, Ogra PL, McGhee JR (eds). Mucosal Vaccines. San Diego: Academic Press, 1996; 303-10.
4. 4 Pang GT, Clancy RL, O'Reilly SE, Cripps AW. A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunisation. J. Virol. 1992; 66: 1162-70.
5. 5 Lidbury BA, Grissell TV, Sizer PJ, Pang GT, Clancy R, Cripps AW. Erythrocytes enhance the immunogenicity of oral vaccination with gamma irradiated influenza virus: Increasing the dose of irradiation results in a significant diminution of lung IgA response. Vaccine 1997; 15: 1529-37.
6. 6 Mbawuike IN, Pacheco S, Acuna CL, Switzer KC, Zhang YX, Harriman GR. Mucosal immunity to influenza without IgA: An IgA knockout mouse model. J. Immunol. 1999; 162: 2530-7.
7. 7 Yap KL, Ada GL. Cytotoxic T cells specific for influenza virus-infected target cells. Immunology 1977; 32: 151-9.
8. 8 Epstein SL, Lo C-Y, Misplon JA, Bennink JR. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 1998; 160: 322-7.
9. + cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 1998; 188: 223-32.
10. 10 Mullbacher A, Ada GL, Tha Hla R. Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol. Cell Biol. 1988; 66: 153-7.
11. 11 Martinon F, Krishnan S, Lenzen G et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 1993; 23: 1719-22.
12. 12 Sastry KJ, Bender BS, Bell W, Small Jr PA, Arlinghaus RB. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus. Vaccine 1994; 12: 1281-7.
13. 13 Liew FY, Russell SM, Appleyard G, Brand CM, Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 1984; 14: 350-6.
14. 14 Tamura S, Funato H, Hirabayashi Y et al. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different haemagglutinin molecules. Eur. J. Immunol. 1991; 21: 1337-44.
15. 15 Asanuma H, Koide F, Suzuki Y et al. Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration. Vaccine 1995; 13: 3-5.
16. 16 Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 1995; 13: 1399-402.
17. 17 Clancy RL, Pang GT, Dunkley ML, Grissell T. Peyer's patch driven protection against influenza using a biomembrane carrier system. In: Brown LE, Hampson AW, Webster RG (eds). Options for the Control of Influenza III. Amsterdam: Elsevier Science BV, 1996; 815-21.
18. 18 Baumgarth N, Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J. Virol. 1996; 70: 4411-18.
19. 19 Hocart MJ, Mackenzie JS, Stewart GA. Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. J. Med. Virol. 1990; 30: 92-6.
20. 20 Powers DC. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J. Med. Virol. 1994; 43: 57-61.
21. 21 Remarque EJ, van Beek WCA, Ligthart GJ et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 1993; 11: 649-54.
22. 22 Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J. Human immune response to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995; 13: 1006-12.